The Future of Post-Surgical Tissue
Care Has Arrived
Introducing B3 GEL™ | The First Flowable Bio-Gel Barrier
Go From Successful Surgery to Successful Movement
When perfectly repaired tendons can't move freely due to post surgical tissue tethering, patients are prevented from returning to normal activities. This creates a gap between surgical repair and functional recovery. TYBR Health is committed to closing this gap with B3 GEL, helping surgical success translate to functional success.
The Real-World Cost of Post Surgical Scarring
Tissue tethering isn’t just a medical complication—they're life-altering events that affect patients, healthcare systems, and society. The numbers tell a compelling story about why our mission matters.
A Proprietary Extracellular Matrix (ECM)
B3 GEL creates a protective barrier that prevents restrictive scar tissue while supporting optimal healing. Its sophisticated ECM structure selectively allows essential nutrients and growth factors to reach tissues while blocking excessive scarring.
During the critical first 7 days post-surgery, B3 GEL remains in place, protecting tissues through the acute inflammation and fibroblast proliferation phases. It then naturally metabolizes over the following 2-3 weeks, leaving no residual or bulky material behind—ensuring protection when needed and complete clearance when healing is established.
Patients Moving Without Limitations
B3 GEL's protective technology delivers what matters most: patients regaining full movement. By reducing excessive post operative tissue tethering, or scarring, during critical healing, successful surgery translates to functional success.
The difference is visible in every bend of a finger, flex of a wrist, or step of a foot—movements that would otherwise be restricted. For surgeons, it means confidence that their expertise will yield expected outcomes. For patients, it means a faster return to the activities that define quality of life.
One Solution, Multiple Applications
B3 GEL's proprietary protection works across multiple tendon and ligament complexes throughout the body. From intricate hand procedures to foot and ankle surgeries, it provides consistent performance while addressing the universal challenge of of unwanted post operative tissue attachments, giving surgeons a single, reliable solution for diverse procedures while maintaining specialized protection for each unique surgical site.
After witnessing countless patients struggle with limited mobility despite technically perfect surgeries, I knew we needed a better solution. B3 GEL isn't just another product—it's our answer to the mobility gap that has frustrated surgeons and patients for decades. We've developed this technology because we believe everyone deserves the full benefit of their surgical intervention: restored function and freedom of movement.
Join the Movement Toward Better Mobility
Ready to bridge the mobility gap for your patients? TYBR Health is currently accepting inquiries from surgeons, distributors, and investors interested in advancing the future of post-surgical tissue care. Tell us a bit about yourself, and our team will be in touch to discuss how B3 GEL can support your goals.
1. Xiao G, Wang J, Zhang N, Hao J.. Front Surg. 2024 May 1;11:1304202 The Cite above is for 12 weeks lost work with Adhesions
2. Lalchandani GR, Halvorson RT, Zhang AL, Lattanza LL, Immerman I.. J Hand Ther. 2022 Oct-Dec;35(4):590-596
3. Medscout data